Jul
27
Obama Wants More Savings By Drugmakers (HGH)
July 27, 2009 | Leave a Comment
John C. Lechleiter, Lilly’s chairman and CEO, warned in a speech at the U.S. Chamber of Commerce in May that health reform proposals could stifle the incentive for drug makers to develop new life-saving and life-extending products.
He is concerned, for example, about the approval process Congress might create for generic versions of biological medicines - like Lilly’s insulin, human growth hormone (HGH) and sepsis treatment. Such a process already exists for drugs, like Prozac, made from chemicals.
Read more about HGH products, what’s safe, what’s not. Straight talk from a doctor…click here!
Recommended Links
GET YOUR FREE HGH &
ANTI-AGING REPORT!
- Get your own FREE copy of the groundbreaking report, "Seven Age Reversing Secrets" – packed with valuable tips and tricks to help you fight the aging process and have the highest quality of life possible!